Dataset opportunity
Healix — 索赔历史数据集机会
由 Healix 持有的中等索赔历史数据集，可用于索赔自动化和欺诈检测。
Score
45
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗索赔管理市场 = 2025 年为 523.3 亿美元，复合年增长率为 24.70%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 🤝Data partnership
AlertMedia 合作整合全球旅行风险和医疗响应数据
source ↗
Profile
Dataset profile
Type
索赔历史数据集
Modality
表格
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（PII 审查）
Buyer persona
InsurTech 和索赔自动化供应商
Healix 持有一个全面的表格 索赔历史数据集，以业务记录、索赔记录和事件流为证。这些细粒度数据非常适合训练和验证索赔自动化人工智能模型，使它们能够更高效、更准确地处理和管理医疗索赔。
全球医疗索赔管理市场规模可观，2025 年估值为523.3 亿美元，预计复合年增长率为 24.70%。这个高增长市场凸显了 Healix 数据的稀有性和价值。虽然访问需要处理敏感的个人身份信息/GDPR 和共享所有权，但买家抓住这个不断增长的市场份额的潜力，使得在强大的匿名化和合规性方面进行必要投资成为一项有价值的战略举措。⚠ 尽职调查（有价值的数据，可协商的访问权限）：包含高度敏感的医疗和个人数据（GDPR/PII）；索赔数据所有权可能与企业医疗信托客户共享；需要强大的匿名化和严格的监管合规性才能进行数据传输 · 企业：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Healix 拥有涵盖超过 200,000 名会员的专有索赔历史数据集。对于 InsurTech 和索赔自动化供应商而言，这些数据是训练和验证下一代人工智能模型的关键资产。在全球医疗索赔市场预计到 2025 年将达到 523.3 亿美元，复合年增长率为 24.70% 的情况下，这个高稀有度的数据集为开发卓越的索赔自动化解决方案提供了显著的竞争优势。
See dimension details ↓- Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=gdpr_敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Dataset Specificity78
主导的“索赔记录”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 次证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适用于索赔自动化
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
人工智能买家需求极高，这得益于在预计复合年增长率为 24.70% 的庞大市场中捕捉效率提升的需求。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Data Orientation39
1 个数据胃口信号（1 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit50
⚠ 审查 — Healix 的核心业务是提供医疗保健/风险管理服务和相关的软件平台（Sentinel），而不是出售休眠数据，因此不适合。问题：公司核心业务包括销售提供风险情报和分析的“Healix Sentinel”软件平台；这是对 ICP 明确排除的情报销售的一种形式；该公司不是中小企业，员工人数在 400 到 700 人之间，超过了典型的 <250 人阈值；使用“Healix”名称的多个不同实体（例如，英国的 Healix International，德克萨斯州的 Healix LLC）可能会造成混淆。
- Deep Qualification80
✓ 通过 — Healix 是数据持有者；它提供医疗保健信托管理和全球风险管理服务，索赔数据是副产品。数据所有权是混合的，因为它代表企业客户，而这些客户的数据很可能归其所有。虽然没有明确限制，但医疗数据的极度敏感性（GDPR）以及其作为客户处理者的角色使得许可复杂化，并且转售权不明。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Claims records
这些表格数据证实 Healix 直接管理着超过 200,000 名会员的索赔历史，为 InsurTech 构建和完善索赔自动化算法提供了基础训练数据。
business_records
这些文件详细说明了 Healix 运营的广泛规模，引用了超过 120 万个实体的全球提供商网络，这为索赔数据增加了关于提供商类型和位置的关键背景信息。
Event streams
来自专有平台的时间序列数据跟踪全球健康事件，为超越标准索赔处理的高级风险建模和预测分析提供了独特的补充信号。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Healix Claims History — a Moderate claims history dataset (Tabular modality) in the healthcare domain. Primary AI use-case: Claims Automation. Market signal: Global healthcare claims management market = $52.33 billion in 2025, CAGR 24.70% (source: Fortune Business Insights).. Investment score 45.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Abundanceinvestment — 公共采购数据集机会
View opportunity →金融Fossandco — 法规记录数据集机会
View opportunity →工业Rob Technologies — 工业传感器数据集机会
View opportunity →